Forbes Medi-Tech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Forbes Medi-Tech

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: Old Stock Collector	10/11/2005 11:28:17 PM
	of 2

Washington Post article today: washingtonpost.com Forbes Medi-Tech's partner McGill University mentioned in the Washington Post article. Research conducted for Forbes at McGill University in Montreal was instrumental in the commercial application of Reducol(tm). McGill has been one of the primary sites for clinical studies of Forbes' nutraceutical products. forbesmedi.com Forbes Medi-Tech Inc. Darren Seed Manager, Investor Relations (604) 681-8976 dseed@forbesmedi.com www.forbesmedi.com Forbes Medi-Tech's Reducol has now been marketed in yogurt & soon to be in other food groups.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext